ONCO: Onconetix, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.52
Enterprise Value ($M) 14.71
Book Value ($M) 1.40
Book Value / Share 0.06
Price / Book 1.80
NCAV ($M) -80.28
NCAV / Share -3.60
Price / NCAV -0.03

Profitability (mra)
Return on Invested Capital (ROIC) -3.31
Return on Assets (ROA) -1.66
Return on Equity (ROE) -1.90

Liquidity (mrq)
Quick Ratio 0.32
Current Ratio 0.34

Balance Sheet (mrq) ($M)
Current Assets 5.84
Assets 87.52
Liabilities 86.11
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.06
Operating Income -15.88
Net Income -37.41

Cash Flow Statement (mra) ($M)
Cash From Operations -13.58
Cash from Investing -8.65
Cash from Financing 1.04

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
01-26 13G/A American Financial Group Inc 7.70 53.17
01-02 13G/A Sabby Management, Llc 4.99 -23.11
12-28 13G Altos Venture AG 5.00 0.00
06-29 13D Cincinnati Cornerstone Investors BWV I, LLC 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 189,379 527,659 35.89
2024-05-02 52,402 14,169 369.84
2024-05-01 152,405 6,587 2,313.72
2024-04-30 6,410 7,445 86.10
2024-04-29 92,209 23,338 395.10

(click for more detail)

Similar Companies
OCUP – Ocuphire Pharma, Inc. OCX – OncoCyte Corporation
OKYO – OKYO Pharma Limited ONCT – Oncternal Therapeutics, Inc.
ONCY – Oncolytics Biotech Inc.


Financial data and stock pages provided by
Fintel.io